AU6048694A
(en)
*
|
1992-12-09 |
1994-07-04 |
Paul D. Jager |
Stabilized medicinal aerosol solution formulations
|
WO1996022081A1
(en)
*
|
1995-01-17 |
1996-07-25 |
Omega Pharmaceutical, Incorporated |
Liquid stable vitamin c compositions and delivery systems, and methods of making and uses thereof
|
US5653961A
(en)
*
|
1995-03-31 |
1997-08-05 |
Minnesota Mining And Manufacturing Company |
Butixocort aerosol formulations in hydrofluorocarbon propellant
|
DK0820279T3
(da)
*
|
1995-04-14 |
2002-10-07 |
Smithkline Beecham Corp |
Dosisudmålende inhalator til Albuterol
|
AU721566B2
(en)
*
|
1995-06-27 |
2000-07-06 |
Boehringer Ingelheim Kg |
New stable pharmaceutical preparation for producing propellant-free aerosols
|
DE19528145A1
(de)
*
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
DE19653969A1
(de)
*
|
1996-12-20 |
1998-06-25 |
Boehringer Ingelheim Kg |
Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
|
US20030215396A1
(en)
|
1999-09-15 |
2003-11-20 |
Boehringer Ingelheim Pharma Kg |
Method for the production of propellant gas-free aerosols from aqueous medicament preparations
|
CA2275889C
(en)
|
1996-12-30 |
2008-03-18 |
Battelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
CZ296966B6
(cs)
*
|
1997-02-24 |
2006-08-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Farmaceutický prostredek
|
GB2326334A
(en)
*
|
1997-06-13 |
1998-12-23 |
Chiesi Farma Spa |
Pharmaceutical aerosol compositions
|
US20010031244A1
(en)
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
AU3065999A
(en)
*
|
1998-03-10 |
1999-09-27 |
Children's Hospital Of Philadelphia, The |
Compositions and methods for treatment of asthma
|
AU759222B2
(en)
*
|
1998-06-18 |
2003-04-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
DE19847968A1
(de)
*
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
DE60031504T2
(de)
|
1999-09-11 |
2007-04-05 |
Glaxo Group Ltd., Greenford |
Fluticasonpropionat arzneizubereitung
|
DE60019167T2
(de)
*
|
1999-12-24 |
2006-05-11 |
Glaxo Group Ltd., Greenford |
Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
IT1317846B1
(it)
*
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
ME00220B
(me)
*
|
2000-05-22 |
2010-10-10 |
Chiesi Farm Spa |
Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
|
DZ3478A1
(fr)
*
|
2000-10-12 |
2002-04-18 |
Boehringer Ingelheim Pharma |
Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
DE10063957A1
(de)
*
|
2000-12-20 |
2002-06-27 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
US20020085978A1
(en)
*
|
2000-11-10 |
2002-07-04 |
Mina Buenafe |
Degradation-resistant glucocorticosteroid formulations
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
EP1241113A1
(de)
|
2001-03-12 |
2002-09-18 |
CHIESI FARMACEUTICI S.p.A. |
Inhalator mit Mitteln um chemische Stabilität der darin enthaltenen medizinischen Aerosollösung zu verbessern
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
US6455028B1
(en)
|
2001-04-23 |
2002-09-24 |
Pharmascience |
Ipratropium formulation for pulmonary inhalation
|
AU2002303425A1
(en)
*
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
TR200401980T4
(tr)
|
2001-07-02 |
2004-09-21 |
Chiesi Farmaceutici S.P.A. |
Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
|
DE10135355C1
(de)
*
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie
|
HU226527B1
(hu)
*
|
2001-09-18 |
2009-03-30 |
Nycomed Danmark Aps |
Készítmények nátha kezelésére
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
US8084461B2
(en)
|
2001-10-26 |
2011-12-27 |
Dey, L.P. |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
NZ550304A
(en)
*
|
2001-10-26 |
2008-05-30 |
Dey L P |
An antimicrobial preservative-free albuterol inhalation solution for the relief of bronchospasm in children with asthma
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
AU3297402A
(en)
*
|
2001-10-26 |
2003-10-30 |
Dey, L.P. |
An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
DE10161368A1
(de)
*
|
2001-12-14 |
2003-07-10 |
Messer Griesheim Gmbh |
Vorrichtung und Verfahren zum kryogenen Abfüllen von Aerosol-Produktansätzen
|
DE60228615D1
(de)
|
2001-12-21 |
2008-10-09 |
3M Innovative Properties Co |
Medizinische aerosolzusammensetzungen mit einer eine amid- und/oder estergruppe enthaltenden exzipientenverbindung
|
JP4959919B2
(ja)
|
2001-12-21 |
2012-06-27 |
スリーエム イノベイティブ プロパティズ カンパニー |
官能基を有するポリエチレングリコール賦形剤を用いた医薬用エアロゾル組成物
|
WO2003059316A1
(en)
*
|
2001-12-21 |
2003-07-24 |
3M Innovative Properties Company |
Medicinal aerosol formulations comprising ion pair complexes
|
PT3494995T
(pt)
*
|
2002-03-01 |
2020-03-30 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
US20040126325A1
(en)
*
|
2002-03-12 |
2004-07-01 |
David Lewis |
Medicinal aerosol solution formulation products with improved chemical stability
|
US7244415B2
(en)
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
US7311894B2
(en)
*
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
US7238661B2
(en)
*
|
2002-05-24 |
2007-07-03 |
Agennix, Inc. |
Oral lactoferrin in the treatment of respiratory disorders
|
JP2006504666A
(ja)
*
|
2002-06-12 |
2006-02-09 |
エピジェネシス ファーマシューティカルズ リミティド ライアビリティー カンパニー |
デヒドロエピアンドロステロン・ステロイド及び抗ムスカリン薬で呼吸器及び肺の疾患を治療するための組成物、配合物及びキット
|
US7056916B2
(en)
*
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
WO2004054580A1
(en)
*
|
2002-12-16 |
2004-07-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing hfc solution formulations
|
KR101113003B1
(ko)
*
|
2003-03-20 |
2012-02-24 |
베링거 인겔하임 파마슈티칼즈, 인코포레이티드 |
추진제로 하이드로-플루오로-알칸을 사용하는 계량 흡입기용 제형
|
EP1915985A1
(de)
*
|
2003-03-20 |
2008-04-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Formulierung für einen Dosierinhalator mit Hydrofluoralkanen als Treibstoffen
|
US7273603B2
(en)
*
|
2003-07-11 |
2007-09-25 |
Boehringer Ingelheim International Gmbh |
HFC solution formulations containing an anticholinergic
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
US20090317476A1
(en)
*
|
2003-07-31 |
2009-12-24 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
US20050101545A1
(en)
*
|
2003-07-31 |
2005-05-12 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
US20050038004A1
(en)
*
|
2003-07-31 |
2005-02-17 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
AR041873A1
(es)
*
|
2003-10-30 |
2005-06-01 |
Pablo Cassara Srl Lab |
Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
|
EP1595531A1
(de)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stabile Arzneimittellösung für Druckdosierinhalatoren
|
KR20070000476A
(ko)
*
|
2004-02-27 |
2007-01-02 |
키에시 파르마슈티시 엣스. 피. 에이. |
압축화 계량된 도스흡입용 안정된 약제용액 제제
|
US20050255050A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Powder formulations for inhalation, comprising enantiomerically pure beta agonists
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
JP5209963B2
(ja)
*
|
2004-07-02 |
2013-06-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
噴霧剤としてtg227ea又はtg134aを含有するエアロゾル懸濁製剤
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
GEP20105040B
(en)
*
|
2005-02-25 |
2010-07-12 |
Chiesi Farm Spa |
Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
|
WO2006114379A1
(de)
*
|
2005-04-23 |
2006-11-02 |
Boehringer Ingelheim International Gmbh |
Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
|
CN101166738B
(zh)
|
2005-05-02 |
2011-06-01 |
贝林格尔·英格海姆国际有限公司 |
噻托溴铵的新晶型
|
PL1917253T3
(pl)
*
|
2005-08-15 |
2015-06-30 |
Boehringer Ingelheim Int |
Sposób wytwarzania betamimetyków
|
WO2007034207A2
(en)
*
|
2005-09-25 |
2007-03-29 |
Cipla Limited |
Troventol formulation
|
US20070088030A1
(en)
*
|
2005-10-10 |
2007-04-19 |
Barbara Niklaus-Humke |
Aerosol formulations for the inhalation of beta-agonists
|
US20070086957A1
(en)
*
|
2005-10-10 |
2007-04-19 |
Thierry Bouyssou |
Combination of medicaments for the treatment of respiratory diseases
|
DE102006017320A1
(de)
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
DE102006023770A1
(de)
*
|
2006-05-20 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Treibgasfreie Aerosolformulierung für die Inhalation
|
US20080131420A1
(en)
*
|
2006-07-13 |
2008-06-05 |
Accentia, Inc. |
Methods and compositions for treating mucosal inflammation
|
EP2077132A1
(de)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
|
EP2100598A1
(de)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
|
EP2100599A1
(de)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
|
EP2201934A1
(de)
|
2008-12-23 |
2010-06-30 |
CHIESI FARMACEUTICI S.p.A. |
Tiotropium-Aerosolformulierungsprodukte mit verbesserter Chemikalienbeständigkeit
|
US10011906B2
(en)
|
2009-03-31 |
2018-07-03 |
Beohringer Ingelheim International Gmbh |
Method for coating a surface of a component
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
CN102905694B
(zh)
|
2009-11-17 |
2015-10-14 |
西普拉有限公司 |
吸入溶液
|
UA107097C2
(en)
|
2009-11-25 |
2014-11-25 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Dispenser
|
WO2011064163A1
(en)
|
2009-11-25 |
2011-06-03 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
EP3020393B1
(de)
|
2009-12-16 |
2020-10-07 |
3M Innovative Properties Company |
Formulierungen und verfahren zur steuerung der mdi-partikelgrössenfreisetzung
|
GEP20156311B
(en)
*
|
2009-12-23 |
2015-07-10 |
Chiesi Farma Spa |
Combination therapy for copd
|
UA106098C2
(uk)
|
2009-12-23 |
2014-07-25 |
К'Єзі Фармачеутічі С.П.А. |
Аерозольна композиція для хозл
|
EP2585151B1
(de)
|
2010-06-24 |
2018-04-04 |
Boehringer Ingelheim International GmbH |
Vernebler
|
JP5409594B2
(ja)
*
|
2010-12-22 |
2014-02-05 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
加圧式定量吸入器のための安定な製薬学的溶液製剤
|
US20120204871A1
(en)
*
|
2011-02-10 |
2012-08-16 |
Julio Cesar Vega |
Stable, non-corrosive formulations for pressurized metered dose inhalers
|
WO2012130757A1
(de)
|
2011-04-01 |
2012-10-04 |
Boehringer Ingelheim International Gmbh |
Medizinisches gerät mit behälter
|
EP2510928A1
(de)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
GB201200504D0
(en)
|
2011-12-19 |
2012-02-22 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhaler
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
JP6335798B2
(ja)
*
|
2012-02-28 |
2018-05-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規噴射剤含有チオトロピウム製剤
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
RU2496477C1
(ru)
*
|
2012-09-20 |
2013-10-27 |
Шолекс Девелопмент Гмбх |
Раствор ипратропия бромида
|
WO2015018904A1
(en)
|
2013-08-09 |
2015-02-12 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
ES2836977T3
(es)
|
2013-08-09 |
2021-06-28 |
Boehringer Ingelheim Int |
Nebulizador
|
RU2536253C1
(ru)
*
|
2013-10-09 |
2014-12-20 |
Шолекс Девелопмент Гмбх |
Комбинированный аэрозольный препарат для лечения болезней органов дыхания
|
CN104968328A
(zh)
*
|
2013-11-22 |
2015-10-07 |
梯瓦优质制药产品研发股份有限公司 |
可吸入药物
|
KR20160101928A
(ko)
|
2013-11-22 |
2016-08-26 |
테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 |
흡입 약제
|
US10195374B2
(en)
|
2014-05-07 |
2019-02-05 |
Boehringer Ingelheim International Gmbh |
Container, nebulizer and use
|
WO2015169430A1
(en)
|
2014-05-07 |
2015-11-12 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
KR102492824B1
(ko)
|
2014-05-07 |
2023-01-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
분무기, 표시 디바이스 및 컨테이너
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
RU2577289C1
(ru)
*
|
2015-03-26 |
2016-03-10 |
Шолекс Девелопмент Гмбх |
Аэрозольный препарат на основе фенотерола гидробромида для лечения заболеваний органов дыхания
|
BR112019005120A2
(pt)
*
|
2016-09-19 |
2019-06-04 |
Mexichem Fluor Sa De Cv |
composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente sofrendo ou susceptível de sofrer de um distúrbio respiratório, para melhorar a estabilidade de uma composição farmacêutica, para melhorar o desempenho de dispersão em aerossol após armazenamento de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica.
|
EP3569221A1
(de)
*
|
2018-05-17 |
2019-11-20 |
Notoxins IP B.V. |
Wässrige formulierungen mit ipratropium zur topischen behandlung von hyperhidrose
|
WO2020152548A1
(en)
*
|
2019-01-24 |
2020-07-30 |
Glenmark Pharmaceuticals Limited |
Stable aerosol inhalation compositions of formoterol
|
GB2584686A
(en)
*
|
2019-06-11 |
2020-12-16 |
Mexichem Fluor Sa De Cv |
Methods
|
CN111297835B
(zh)
*
|
2019-12-20 |
2022-11-25 |
上海方予健康医药科技有限公司 |
含抗胆碱能药物的吸入气雾剂及其制备工艺和使用方法
|
JP2023546025A
(ja)
*
|
2020-10-09 |
2023-11-01 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
加圧定量吸入器のための医薬製剤
|